Strategic, solutions-oriented executive leader with deep expertise in aligning science, operations, and regulatory strategy to drive enterprise growth. Board-certified in Medical and Public Health Microbiology and Medical Laboratory Science, with recognized leadership in molecular diagnostics and the laboratory diagnosis of sexually transmitted infections. Co-author of 20+ peer-reviewed publications and scientific collaborator with the CDC; led lab-developed test validation and regulatory approval through the New York State Wadsworth Center. Served as Principal Investigator for in vitro diagnostic device trials with Roche, Hologic, Abbott, and BD, and a frequent presenter at national and international scientific conferences for more than two decades. Proven track record delivering automation initiatives that increase capacity, improve quality, and reduce time-to-result, combined with strong scientific communication skills, including media engagement. Dedicated advocate for women in science and leadership, actively engaged in mentoring and ERG initiatives; graduate of Labcorp’s ELEVATE program (2022) and recipient of the Healthcare Businesswomen’s Association Luminary Award (2024).
Areas of Support: Molecular Infectious Disease, Molecular Microbiology, Routine Microbiology